With respect to its immunomodulatory role, treatment with recombinant human CRYAB was demonstrated to dampen the inflammatory response in injured spinal cord [32] while mice that are null for the heat shock protein display enhanced T cell and macrophage activation in experimental allergic encephalomyelitis [33–35] and stroke [36, 37]. The gene discussed is CRYAB; the disease is stroke disorder.